Real-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation
Blood Cancer Journal, Published online: 26 June 2023; doi:10.1038/s41408-023-00868-wReal-world data of long-term survival in patients with T-cell lymphoma who underwent stem cell transplantation (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 26, 2023 Category: Hematology Authors: Dong Won Baek Joon Ho Moon Jae Hoon Lee Ka-Won Kang Ho Sup Lee Hyeon-Seok Eom Enuyoung Lee Ji Hyun Lee Jeong-Ok Lee Seong Kyu Park Seok Jin Kim Keon Hee Yoo Sung-Soo Yoon Youngil Koh Hyoung Jin Kang Jong-Ho Won Chuhl Joo Lyu Seung Min Hahn Jung-Hee Lee Jo Source Type: research
The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas
Blood Cancer Journal, Published online: 26 June 2023; doi:10.1038/s41408-023-00872-0The DNA methylation status of the TERT promoter differs between subtypes of mature B-cell lymphomas (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 26, 2023 Category: Hematology Authors: Alexandra G. Kouroukli Anja Fischer Helene Kretzmer Emil Chteinberg Nivethika Rajaram Selina Glaser Julia Kolarova Pavel Bashtrykov Stephan Mathas Hans G. Drexler Hitoshi Ohno Ole Ammerpohl Albert Jeltsch Reiner Siebert Susanne Bens Source Type: research
Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation
Blood Cancer Journal, Published online: 26 June 2023; doi:10.1038/s41408-023-00867-xMonitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 26, 2023 Category: Hematology Authors: Jong-Mi Lee Ari Ahn Eun Jeong Min Sung-Eun Lee Myungshin Kim Yonggoo Kim Source Type: research
A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease
Blood Cancer Journal, Published online: 26 June 2023; doi:10.1038/s41408-023-00876-wA reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 26, 2023 Category: Hematology Authors: Steven M. Johnson James Haberberger Jonathan Galeotti Lori Ramkissoon Catherine C. Coombs Daniel R. Richardson Matthew C. Foster Daniel Duncan Joshua F. Zeidner Naomi L. Ferguson Nathan D. Montgomery Source Type: research
Intracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse
Blood Cancer Journal, Published online: 22 June 2023; doi:10.1038/s41408-023-00873-zIntracranial bleeding in acute promyelocytic leukemia treated with arsenic trioxide based regimens is associated with induction mortality but not with relapse (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 22, 2023 Category: Hematology Authors: Uday Prakash Kulkarni Sushil Selvarajan N. A. Fouzia Sharon Lionel Sukesh Chandran Nair Poonkuzhali Balasubramanian Thenmozhi Mani Aby Abraham Biju George Vikram Mathews Source Type: research
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
Blood Cancer Journal, Published online: 19 June 2023; doi:10.1038/s41408-023-00850-6Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 19, 2023 Category: Hematology Authors: Jacobien R. Hilberink Isabelle A. van Zeventer Dana A. Chitu Thomas Pabst Saskia K. Klein Georg Stussi Laimonas Griskevicius Peter J. M. Valk Jacqueline Cloos Arjan A. van de Loosdrecht Dimitri Breems Danielle van Lammeren-Venema Rinske Boersma Mojca Jong Source Type: research
Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia
Blood Cancer Journal, Published online: 08 June 2023; doi:10.1038/s41408-023-00863-1Integrated multi-omics analyses reveal homology-directed repair pathway as a unique dependency in near-haploid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 8, 2023 Category: Hematology Authors: Yunpeng Liu-Lupo James Dongjoo Ham Swarna K. A. Jeewajee Lan Nguyen Toni Delorey Azucena Ramos David M. Weinstock Aviv Regev Michael T. Hemann Source Type: research
Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience
Blood Cancer Journal, Published online: 31 May 2023; doi:10.1038/s41408-023-00859-xDaratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 31, 2023 Category: Hematology Authors: I. Vaxman S. K. Kumar F. Buadi M. Q. Lacy D. Dingli S. Hayman T. Kourelis R. Warsame Y. Hwa A. Fonder M. Hobbs E. Muchtar N. Leung P. Kapoor R. Go Y. Lin W. Gonsalves M. Siddiqui R. A. Kyle S. V. Rajkumar M. A. Gertz A. Dispenzieri Source Type: research
Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma
Blood Cancer Journal, Published online: 30 May 2023; doi:10.1038/s41408-023-00864-0Should I stay or should I go (to transplant)? Managing insufficient responses to induction in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 30, 2023 Category: Hematology Authors: Rahul Banerjee Louis Williams Joseph R. Mikhael Source Type: research
Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy
Blood Cancer Journal, Published online: 30 May 2023; doi:10.1038/s41408-023-00861-3Exercise-induced release of cardiac and skeletal muscle injury biomarkers in patients with chronic myeloid leukemia receiving TKI therapy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 30, 2023 Category: Hematology Authors: Lando Janssen Neeltje A. E. Allard Vincent L. Aengevaeren Thijs M. H. Eijsvogels Silvie Timmers Nicole M. A. Blijlevens Maria T. E. Hopman Source Type: research
UBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome
Blood Cancer Journal, Published online: 26 May 2023; doi:10.1038/s41408-023-00858-yUBTF tandem duplications are rare but recurrent alterations in adult AML and associated with younger age, myelodysplasia, and inferior outcome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 26, 2023 Category: Hematology Authors: Julia-Annabell Georgi Sebastian Stasik Jan-Niklas Eckardt Sven Zukunft Marita Hartwig Christoph R öllig Jan Moritz Middeke Uta Oelschl ägel Utz Krug Tim Sauer Sebastian Scholl Andreas Hochhaus Tim H. Br ümmendorf Ralph Naumann Bj örn Steffen Hermann E Source Type: research
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients
Blood Cancer Journal, Published online: 26 May 2023; doi:10.1038/s41408-023-00856-0Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 26, 2023 Category: Hematology Authors: Rodrigo Fonseca Mariano Arribas Julia E. Wiedmeier-Nutor Yael N. Kusne Miguel Gonz ález Vélez Heidi E. Kosiorek Richard (Duke) J. Butterfield Ilan R. Kirsch Joseph R. Mikhael A. Keith Stewart Craig Reeder Jeremy Larsen P. Leif Bergsagel Rafael Fonseca Source Type: research
A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
Blood Cancer Journal, Published online: 22 May 2023; doi:10.1038/s41408-023-00854-2A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2023 Category: Hematology Authors: A. Vera de Jonge Erik van Werkhoven Avinash G. Dinmohamed Marcel Nijland Aeilko H. Zwinderman Patrick M. Bossuyt Martine S. Veldhuis Emma G. G. M. Rutten Rogier Mous Joost S. P. Vermaat Yorick Sandberg Eva de Jongh Yavuz M. Bilgin Rinske Boersma Harry Koe Source Type: research
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma
Blood Cancer Journal, Published online: 22 May 2023; doi:10.1038/s41408-023-00851-5Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2023 Category: Hematology Authors: Linda B. Baughn Erik Jessen Neeraj Sharma Hongwei Tang James B. Smadbeck Mark D. Long Kathryn Pearce Matthew Smith Surendra Dasari Zohar Sachs Michael A. Linden Joselle Cook A. Keith Stewart Marta Chesi Amit Mitra P. Leif Bergsagel Brian Van Ness Shaji K. Source Type: research
High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma
Blood Cancer Journal, Published online: 22 May 2023; doi:10.1038/s41408-023-00855-1High SOX2 expression is associated with poor survival in patients with newly diagnosed multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - May 22, 2023 Category: Hematology Authors: Xinhe Shan Qi Long Alfred L. Garfall Sandra P. Susanibar-Adaniya Source Type: research
